Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Complete vs. incomplete percutaneous revascularization in patients with chronic total coronary artery occlusion.
Maestre-Luque LC, Gonzalez-Manzanares R, Suárez de Lezo J, Hidalgo F, Barreiro-Mesa L, de Juan J, Gallo I, Perea J, Alvarado M, Romero M, Ojeda S, Pan M. Maestre-Luque LC, et al. Among authors: alvarado m. Front Cardiovasc Med. 2024 Jul 23;11:1443258. doi: 10.3389/fcvm.2024.1443258. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39108670 Free PMC article.
Very long-term follow-up after aortic stenting for coarctation of the aorta.
Pan M, Pericet C, González-Manzanares R, Díaz MA, Suárez de Lezo J, Hidalgo F, Alvarado M, Dueñas G, Gómez E, Espejo S, Perea J, Romero M, Ojeda S. Pan M, et al. Among authors: alvarado m. Rev Esp Cardiol (Engl Ed). 2024 Apr;77(4):332-341. doi: 10.1016/j.rec.2023.10.004. Epub 2023 Nov 21. Rev Esp Cardiol (Engl Ed). 2024. PMID: 37981191 English, Spanish.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
Baumbach A, van Royen N, Amat-Santos IJ, Hudec M, Bunc M, Ijsselmuiden A, Laanmets P, Unic D, Merkely B, Hermanides RS, Ninios V, Protasiewicz M, Rensing BJWM, Martin PL, Feres F, De Sousa Almeida M, van Belle E, Linke A, Ielasi A, Montorfano M, Webster M, Toutouzas K, Teiger E, Bedogni F, Voskuil M, Pan M, Angerås O, Kim WK, Rothe J, Kristić I, Peral V, Garg S, Elzomor H, Tobe A, Morice MC, Onuma Y, Soliman O, Serruys PW; LANDMARK trial investigators. Baumbach A, et al. Lancet. 2024 Jun 22;403(10445):2695-2708. doi: 10.1016/S0140-6736(24)00821-3. Epub 2024 May 22. Lancet. 2024. PMID: 38795719 Clinical Trial.
The good, the bad, and the hazardous: comparative genomic analysis unveils cell wall features in the pathogen Candidozyma auris typical for both baker's yeast and Candida.
Alvarado M, Gómez-Navajas JA, Blázquez-Muñoz MT, Gómez-Molero E, Fernández-Sánchez S, Eraso E, Munro CA, Valentín E, Mateo E, de Groot PWJ. Alvarado M, et al. FEMS Yeast Res. 2024 Jan 9;24:foae039. doi: 10.1093/femsyr/foae039. FEMS Yeast Res. 2024. PMID: 39656857 Free PMC article.
558 results